文献速递肝病消化道肿瘤与早癌

多倍体谱:肝细胞癌分类的新标志物

Polyploidy spectrum: a new marker in HCC classification.
PubMed 文献 · Gut · 2019-04-12

研究通过原位成像定量分析手术切除的肝细胞癌(HCC)组织及健康对照肝组织的倍体谱,发现HCC中细胞倍体大幅降低、核倍体特异性扩增,核倍体扩增与低分化和TP53突变相关,高多倍体肿瘤预后不良。

要点

  • 健康肝实质以多倍体肝细胞为主,主要为双核肝细胞,无特定分区模式。
  • HCC中细胞倍体大幅降低,双核多倍体肝细胞几乎消失。
  • HCC中核倍体特异性扩增,与低分化和TP53突变相关,高多倍体肿瘤预后不良。

核心结论

  • 肝细胞癌发生过程中细胞倍体与核倍体谱的定量分析具有重要意义。

研究设计与样本

  • 对手术切除的肝细胞癌(HCC)组织及健康对照肝组织,采用定性和定量原位成像方法在石蜡肝组织切片上确定倍体谱。

主要发现

  • 健康肝实质以多倍体肝细胞为主,多倍体主要为细胞性(双核肝细胞),且在小叶内无特定分区模式。
  • HCC中细胞倍体大幅降低,双核多倍体肝细胞几乎不存在。
  • HCC中核倍体特异性扩增,且在低分化及携带TP53突变的HCC中核倍体扩增。
  • 高多倍体肿瘤与不良预后相关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Polyploidy is a fascinating characteristic of liver parenchyma. Hepatocyte polyploidy depends on the DNA content of each nucleus (nuclear ploidy) and the number of nuclei per cell (cellular ploidy). Which role can be assigned to polyploidy during human hepatocellular carcinoma (HCC) development is still an open question. Here, we investigated whether a specific ploidy spectrum is associated with clinical and molecular features of HCC. DESIGN: Ploidy spectra were determined on surgically resected tissues from patients with HCC as well as healthy control tissues. To define ploidy profiles, a quantitative and qualitative in situ imaging approach was used on paraffin tissue liver sections. RESULTS: We first demonstrated that polyploid hepatocytes are the major components of human liver parenchyma, polyploidy being mainly cellular (binuclear hepatocytes). Across liver lobules, polyploid hepatocytes do not exhibit a specific zonation pattern. During liver tumorigenesis, cellular ploidy is drastically reduced; binuclear polyploid hepatocytes are barely present in HCC tumours. Remarkably, nuclear ploidy is specifically amplified in HCC tumours. In fact, nuclear ploidy is amplified in HCCs harbouring a low degree of differentiation and TP53 mutations. Finally, our results demonstrated that highly polyploid tumours are associated with a poor prognosis. CONCLUSIONS: Our results underline the importance of quantification of cellular and nuclear ploidy spectra during HCC tumorigenesis.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Bou-Nader M, Caruso S, Donne R, et al. Polyploidy spectrum: a new marker in HCC classification. Gut. 2019. PMID: 30979717. doi:10.1136/gutjnl-2018-318021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。